Who are Dogwood Therapeutics, Inc.'s main suppliers?

Dogwood Therapeutics, Inc. (DWTX) key suppliers include: UNIVERSITY-OF-ALABAMA, ORANY, ORANY, Tonix Pharmaceuticals Holding Corp.. View the full supplier network at chainsifter.com/chain/DWTX.

Who are Dogwood Therapeutics, Inc.'s major customers?

Dogwood Therapeutics, Inc. (DWTX) key customers include: PRIDCOR-THERAPEUTICS-LLC, ORANY, ORANY, Tonix Pharmaceuticals Holding Corp., INNOVATIVE-MED-CONCEPTS-LLC and 6 more. View the full customer network at chainsifter.com/chain/DWTX.

What sector is Dogwood Therapeutics, Inc. in?

Dogwood Therapeutics, Inc. (DWTX) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Dogwood Therapeutics, Inc. Suppliers, Customers & Supply Chain (DWTX)

4Suppliers

11Customers

3Debt Items

20Related Chains

Source-Backed Evidence Depth

Dogwood Therapeutics, Inc. (DWTX) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

19Total relationships

4Distinct source URLs

6High confidence

0.741Average confidence

2026-10-28Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Dogwood Therapeutics, Inc. Suppliers

Ticker	Name	Confidence	Evidence
UNIVERSITY-OF-ALABAMA	UNIVERSITY-OF-ALABAMA	90%	In consideration for the License Agreement, the University of Alabama received membership interests in the Company representing 10% of the issued membership interests at that time.
ORANY	ORANY	72%	Reciprocal relationship from ORANY graph: Reciprocal relationship from DWTX graph: ct which will be distributed to the clinical sites for reconstitution and use in clinical trials. We are presently d…
ORANY	ORANY	72%	ct which will be distributed to the clinical sites for reconstitution and use in clinical trials. We are presently developing a synthetically formulated version of Halneuron ® to be used for both Pha…
TNXP	Tonix Pharmaceuticals Holding Corp.	72%	Reciprocal relationship from TNXP graph: Reciprocal relationship from DWTX graph: Reciprocal relationship from TNXP graph: Reciprocal relationship from DWTX graph: Reciprocal relationship from TNXP g…

Dogwood Therapeutics, Inc. Customers

Ticker	Name	Confidence	Evidence
PRIDCOR-THERAPEUTICS-LLC	PRIDCOR-THERAPEUTICS-LLC	92%	In exchange, the Company is entitled to a tiered royalty on net sales of up to 15 % upon commercialization of IMC-1 or IMC-2.
ORANY	ORANY	72%	Reciprocal relationship from ORANY graph: Reciprocal relationship from DWTX graph: Reciprocal relationship from ORANY graph: Reciprocal relationship from DWTX graph: s or the imposition of civil or c…
ORANY	ORANY	72%	s or the imposition of civil or criminal penalties. The FDA strictly regulates marketing, labeling, advertising and promotion of products that are placed on the market. Drugs or devices may be promot…
TNXP	Tonix Pharmaceuticals Holding Corp.	72%	Reciprocal relationship from TNXP graph: Reciprocal relationship from DWTX graph: Reciprocal relationship from TNXP graph: Reciprocal relationship from DWTX graph: Reciprocal relationship from TNXP g…
INNOVATIVE-MED-CONCEPTS-LLC	INNOVATIVE-MED-CONCEPTS-LLC	62%	any”) as of December 31, 2025 and 2024, the related consolidated statements of operations and comprehensive loss, changes in Series A non-voting convertible preferred stock and stockholders’ equity (…
MAXIM-GROUP-LLC	MAXIM-GROUP-LLC	62%	lion related to the Combination with Pharmagesic in October 2024 and a decrease in expenses associated with being a pubic company of $0.2 million offset by increases in salaries and related personnel…
ORGANIZATION-DOGWOOD-THERAPEUTICS-INC	ORGANIZATION-DOGWOOD-THERAPEUTICS-INC	62%	any”) as of December 31, 2025 and 2024, the related consolidated statements of operations and comprehensive loss, changes in Series A non-voting convertible preferred stock and stockholders’ equity (…
REJUVENATION-LABS-INC	REJUVENATION-LABS-INC	62%	versity of Alabama reserved the right to use the Technical Information for educational, research, clinical, and other non-commercial purposes. We may assign the license to any purchaser or transferee…
SERPIN-PHARMA-INC	SERPIN-PHARMA-INC	62%	versity of Alabama reserved the right to use the Technical Information for educational, research, clinical, and other non-commercial purposes. We may assign the license to any purchaser or transferee…
VIRIOS-THERAPEUTICS-INC	VIRIOS-THERAPEUTICS-INC	62%	any”) as of December 31, 2025 and 2024, the related consolidated statements of operations and comprehensive loss, changes in Series A non-voting convertible preferred stock and stockholders’ equity (…
VIRIOS-THERAPEUTICS-LLC	VIRIOS-THERAPEUTICS-LLC	62%	any”) as of December 31, 2025 and 2024, the related consolidated statements of operations and comprehensive loss, changes in Series A non-voting convertible preferred stock and stockholders’ equity (…

Dogwood Therapeutics, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
DWTX-DEBT	Debt stack $162,604	90%	Market cache reports total debt of $162,604.
DWTX-DEBT-9186	Warrants outstanding: 20000	90%	xbrl warrant detail from xbrl 2022-09-30.
DWTX-DEBT-9187	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2025-12-31.

Dogwood Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Dogwood Therapeutics, Inc..

Dogwood Therapeutics, Inc. Ownership

Holder	Name	Confidence	Evidence
DWTX-OWNER-ARMISTICE-CAPITAL-LLC	ARMISTICE CAPITAL, LLC	90%	13F overlay lists ARMISTICE CAPITAL, LLC as top holder; 15 tracked holders.

Dogwood Therapeutics, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
DFTX	Definium Therapeutics, Inc.	100.00	2
AZN	AstraZeneca PLC	100.00	2
TNXP	Tonix Pharmaceuticals Holding Corp.	100.00	1	['customer', 'supplier']
AXSM	Axsome Therapeutics, Inc.	100.00	2
ORANY	ORANGE	100.00	1	['customer', 'supplier']
JNJ	Johnson & Johnson	100.00	2
BFRGW	BullFrog AI Holdings, Inc.	50.00	2
ASBPW	Aspire Biopharma Holdings, Inc.	50.00	2
BCDRF	Banco Santander, S.A.	50.00	2
CPRX	Catalyst Pharmaceuticals, Inc.	50.00	2
ARQQW	Arqit Quantum Inc.	50.00	2
AYTU	Aytu BioPharma, Inc.	50.00	2
CYCN	Cyclerion Therapeutics, Inc.	50.00	2
CMCM	Cheetah Mobile Inc.	50.00	2
AMZE	Amaze Holdings, Inc.	50.00	2
BLTE	Belite Bio, Inc	50.00	2
DARE	Daré Bioscience, Inc.	50.00	2
CINGW	Cingulate Inc.	50.00	2
EPDU	ENTERPRISE PRODUCTS PARTNERS L.P.	50.00	2
BFRIW	Biofrontera Inc.	50.00	2

Dogwood Therapeutics, Inc. Supply Chain